A significant change for one of Australia's leading patient advocates with the co-founder and CEO of NeuroEndocrine Cancer Australia departing the organisation after 13 years. …
Major change for leading patient advocate with move to emerging Australian company
October 13, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
Mark Butler starts the process of NDIS pricing reform
June 11, 2025 - - Latest News -
Pfizer chief sets out the potential implications of 'Most Favored Nation' pricing
June 11, 2025 - - Latest News -
What will the HTA Review Implementation Advisory Group do if the PBAC rejects the process?
June 11, 2025 - - Latest News -
Advocacy group 'pleading' with the NSW Government to establish Men B vaccine program
June 10, 2025 - - Latest News -
New study reveals superior efficacy of cell-based flu vaccine
June 10, 2025 - - Latest News -
Medicines Australia says delayed listings would not be a surprising response
June 10, 2025 - - Latest News -
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 - - Latest News